FDA adds rare vision-loss warning to popular obesity, diabetes drugs

Coverage, in order

1. 1d ago
   
   The Hindu Health India mainstream

   FDA adds rare vision-loss warning to popular obesity, diabetes drugs

   The eye condition, known as non-arteritic anterior ischemic optic neuropathy, can cause significant vision loss and has been reported with all GLP-1 drugs,

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.